Teva Pharma Industries Ltd ADR
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $4,176,000 | $3,891,000 | $4,229,000 | $4,332,000 |
Gross Profit | 2,102,000 | 1,877,000 | 2,120,000 | 2,148,000 |
EBITDA | 657,000 | 763,000 | 261,000 | 217,000 |
EBIT | 406,000 | 519,000 | -8,000 | -42,000 |
Net Income | 282,000 | 214,000 | -217,000 | -437,000 |
Net Change In Cash | 4,176,000 | 3,891,000 | 4,229,000 | 4,332,000 |
Free Cash Flow | 227,000 | -232,000 | 446,000 | 545,000 |
Cash | 2,161,000 | 1,697,000 | 3,300,000 | 3,319,000 |
Basic Shares | 1,161,000 | 1,159,000 | 1,133,000 | 1,133,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $16,544,000 | $15,846,000 | $14,925,000 | $15,878,000 |
Gross Profit | 8,064,000 | 7,645,000 | 6,973,000 | 7,594,000 |
EBITDA | 777,000 | 433,000 | -874,000 | 2,994,000 |
EBIT | -282,000 | 433,000 | -2,182,000 | 1,664,000 |
Net Income | -1,639,000 | -559,000 | -2,446,000 | 417,000 |
Net Change In Cash | 16,544,000 | 15,846,000 | 14,925,000 | 15,878,000 |
Cost of Revenue | 149,000 | |||
Free Cash Flow | 749,000 | 842,000 | 1,042,000 | 236,000 |
Cash | 3,300,000 | 3,226,000 | 2,801,000 | 2,165,000 |
Basic Shares | 1,131,000 | 1,119,000 | 1,110,000 | 1,107,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.66 |
2025-03-31 | $0.52 |
2024-12-31 | $0.71 |
